198 related articles for article (PubMed ID: 12512139)
21. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
Kornely E; Schlaghecke R
Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209
[TBL] [Abstract][Full Text] [Related]
22. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
23. [A case of virilizing adrenocortical carcinoma in adult].
Tsujimura A; Imazu T; Nishimura K; Matsumiya K; Sugao H; Oka T; Takaha M; Arima R; Kurata A
Hinyokika Kiyo; 1993 Apr; 39(4):345-8. PubMed ID: 8503331
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
Berruti A; Fassnacht M; Baudin E; Hammer G; Haak H; Leboulleux S; Skogseid B; Allolio B; Terzolo M
J Clin Oncol; 2010 Aug; 28(23):e401-2; author reply e403. PubMed ID: 20567001
[No Abstract] [Full Text] [Related]
25. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies.
Demeure MJ; Somberg LB
Surg Oncol Clin N Am; 1998 Oct; 7(4):791-805. PubMed ID: 9735134
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival after bilateral adrenalectomy for metachronous adrenocortical cancer.
Hara I; Sakamoto Y; Kanomata N; Muramaki M; Yamada Y; Kawabata G; Kamidono S
Int J Urol; 2004 Dec; 11(12):1127-9. PubMed ID: 15663687
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant mitotane in adrenocortical carcinoma.
Machens A; Dralle H
N Engl J Med; 2007 Sep; 357(12):1258-9; author reply 1259. PubMed ID: 17891837
[No Abstract] [Full Text] [Related]
28. [A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Otai J; Mikata K; Tsuchiya F; Nagashima Y
Hinyokika Kiyo; 2007 Sep; 53(9):623-6. PubMed ID: 17933137
[TBL] [Abstract][Full Text] [Related]
29. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
30. ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.
Yarom N; Stewart D; Avruch L; Malik R; Wells J; Jonker DJ
Anticancer Res; 2011 Nov; 31(11):3921-5. PubMed ID: 22110220
[TBL] [Abstract][Full Text] [Related]
31. [Small cell carcinoma of the urinary bladder: a case report].
Yokoyama S; Tsutahara K; Fukuhara S; Mori N; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2005 Jun; 51(6):403-5. PubMed ID: 16050481
[TBL] [Abstract][Full Text] [Related]
32. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant mitotane in adrenocortical carcinoma.
Lee JE
N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836
[No Abstract] [Full Text] [Related]
34. [Therapy of the adrenocortical carcinoma with Lysodren (o,p'-DDD). Therapeutic management by monitoring o,p'-DDD blood levels].
Heilmann P; Wagner P; Nawroth PP; Ziegler R
Med Klin (Munich); 2001 Jul; 96(7):371-7. PubMed ID: 11494911
[TBL] [Abstract][Full Text] [Related]
35. Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.
Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L
J Endocrinol Invest; 2006 Jun; 29(6):560-2. PubMed ID: 16840836
[TBL] [Abstract][Full Text] [Related]
36. [The adrenocortical carcinoma, a tumour of wide clinical diversity].
Schreinemakers JM; van Dam PS; Seldenrijk CA; Biesma DH; Borel Rinkes IH
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2109-13. PubMed ID: 15553352
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant mitotane in adrenocortical carcinoma.
Dickstein G; Shechner C; Nativ O
N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
[No Abstract] [Full Text] [Related]
38. Adjuvant mitotane in adrenocortical carcinoma.
Bertherat J; Coste J; Bertagna X
N Engl J Med; 2007 Sep; 357(12):1256-7; author reply 1259. PubMed ID: 17881760
[No Abstract] [Full Text] [Related]
39. [Case report on metastasis surgery in adrenal cortex cancer].
Buchholz NP; Süberli H; Ausfeld R
Urologe A; 1992 Jan; 31(1):14-8. PubMed ID: 1553798
[TBL] [Abstract][Full Text] [Related]
40. Medical therapy of adrenocortical tumors.
Kletter GB
Minerva Endocrinol; 2009 Jun; 34(2):149-59. PubMed ID: 19471239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
